GLENMARK PHARMACEUTICALS USA

NJ

Pharmaceutical manufacturing

Filings
33
Firms Hired
1
Total Expenses
$4,851,421
Years Active
2017–2024

Filings

All 20242023202220212020201920182017
YearFirmPeriodExpensesDoc
2024 GLENMARK PHARMACEUTICALS USA 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination (No Activity) 		—
2024 GLENMARK PHARMACEUTICALS USA 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report (No Activity) 		—
2023 GLENMARK PHARMACEUTICALS USA 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity) 		—
2023 GLENMARK PHARMACEUTICALS USA 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity) 		—
2023 GLENMARK PHARMACEUTICALS USA 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report (No Activity) 		—
2023 GLENMARK PHARMACEUTICALS USA 1st Quarter (Jan 1 - Mar 31)
AMENDED 		—
2023 GLENMARK PHARMACEUTICALS USA 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report (No Activity) 		—
2022 GLENMARK PHARMACEUTICALS USA 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity) 		—
2022 GLENMARK PHARMACEUTICALS USA 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Termination 		$115,000
2022 GLENMARK PHARMACEUTICALS USA 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$136,000
Page 1 of 4  ·  33 filings Next
Firms Hired
FirmFilingsExpenses
GLENMARK PHARMACEUTICALS USA 33 $4,851,421
Issue Areas
IssueActivities
Health Issues 25
Medicare/Medicaid 19
Taxation/Internal Revenue Code 2
Copyright/Patent/Trademark 2

Bills Mentioned in Filings

HR 938 S. 64 HR 1506 HR 1499 HR 749 HR 2212